Connect with us

Science

Do These Penny Stocks Present a Buying Opportunity At Current Prices?

Are these penny stocks worth buying at their current level? Take a look and find out
The post Do These Penny Stocks Present a Buying Opportunity At Current Prices? appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Published

on

3 Penny Stocks to Add to Your September 2021 Watchlist 

While many penny stocks investors often look to stocks that are big gainers for their watchlists, there is plenty of opportunity with stocks that may be down on a trading day. With penny stocks or blue chips, there is always a natural ebb and flow in the market. 

With the exception of news-related price movements, shares will always move up and down alongside speculation and fundamentals. So, if a stock is down one day, it could move up the next and vice versa. This is in no way a guarantee of price movement, however, it can be a unique strategy to utilize when making a penny stock watchlist

[Read More] Best Penny Stocks For Retail Traders to Buy? 3 For Your List

As mentioned earlier, investors should keep in mind that bad news will often affect a stock negatively. But, a stock moving down with no news at all, could be worth watching for an eventual uptick. As always, use the research tools at your disposal to ensure that a penny stock is worth buying. Considering this, let’s take a look at three penny stocks to see whether or not they are worth buying at current prices. 

3 Penny Stocks to Watch in September 2021 

  1. Transocean Ltd. (NYSE: RIG
  2. IAMGOLD Corp. (NYSE: IAG
  3. Enzolytics Inc. (OTC: ENZC

Transocean Ltd. (NYSE: RIG)

Transocean Ltd. is a penny stock that is down by around 4% at EOD on September 16th. However, in the past month, shares have climbed by over 12% for a one-year gain of over 220%. At its current price, does RIG stock present a buying opportunity? Well, to understand this, let’s go a step deeper. This is a company that provides offshore contract drilling services. Transocean contracts drilling rigs, equipment, and work crews. The company owns or has partial ownership in 37 mobile offshore drilling units, 27 deepwater, and 10 harsh environment floaters.  

Back in early August, the company reported its second-quarter results for 2021. The company’s total contract drilling revenues were at $656 million for the quarter. Transocean’s revenue efficiency was 98% compared to 97.4% the previous quarter. Now the company has announced that it secured a $252 million contract for a newbuild ultra-deepwater drillship, the Deepwater Atlas. This deal includes a mobilization fee of $30 million along with other milestone payments. All of this is exciting news for the company, and especially so considering the current state of the shipping market. 

President and CEO Jeremy Thigpen said, “We are extremely pleased to have secured the maiden contract for the Deepwater Atlas; the first of our two 8th generation ultra-deepwater drillships that will enter the market in 2022, both of which will be outfitted for 20,000 psi ultra-deepwater well operations.” With so much new information to keep in mind, will RIG make your list of penny stocks to watch?

IAMGOLD Corporation (NYSE: IAG)

IAMGOLD Corporation is another penny stock that may be down on the day, but it is up by around 5% in the past five days or so. Over the course of the year, IAG stock managed to climb and then fall back down to its current price of just north of $2.30 per share. But, with gold stocks heating up right now, IAG could present an interesting opportunity.

This company develops and operates various gold mining properties in several countries. It currently operates out of North America, South America, and West Africa. IAMGOLD has active interests in the Essakane mine, Rosebel mine, and Westwood mine among many others in these locations.

[Read More] Best Penny Stocks to Watch as Meme Stocks See Another Surge

Back in August, IAMGOLD released its second-quarter financial results for the year. This mining stock is still recovering from the pandemic at the moment. As a result of Covid-related troubles, IAG did not perform as well as hoped during the second quarter of the year. But, some investors are hopeful for a brighter Q3 2021 which will be reflected in its next quarterly report.

“The second quarter of 2021 was challenging primarily because production from our Rosebel mine was unexpectedly adversely affected by unusually heavy rains and an increase in COVID-19 cases in Suriname, in addition to difficult industrial relations.”

The President and CEO of IAMGOLD, Gordon Stothart

It’s worth considering that IAG stock tends to move with the price of gold itself. And as a result, if you’re interested in IAG or any gold stock, it is worth keeping a close eye on the industry as a whole. It will be interesting to see what the future performance of the company is going into the second half of September. For now, will this company be on your penny stocks watchlist?

Penny_Stocks_to_Watch_IAMGOLD_Corporation_(IAG_Stock_Chart)

Enzolytics Inc. (OTC: ENZC)

Enzolytics Inc. is a biotech penny stock that is down today following a major gain in the previous trading day. For the past five days and the YTD period, ENZC stock is up by around 17% and 100% respectively. This company focuses on commercializing products for treating infectious diseases. It currently has anti-HIV therapeutics that utilize non-toxic passive immunotherapy. Its current anti-HIV treatments are clinically tested and in the various trial stages, which is exciting for investors to consider. 

On July 29th, the company reported its progress toward completing clinical trials for its ITV-1 anti-HIV therapeutic. It also reported its progress towards securing use authorization from the European Medicines Agency. Enzolytics has completed arrangements and agreements with Danhson and Clinic Design to advance its product to production and clinical trials. These steps are necessary to receive approval from the EMA.

“As this is the second time our ITV-1 therapeutic has progressed through clinical trials and the first trials were successful, we are fully confident that we will succeed in the permitting process. With the reciprocal treaty between the EMA and FDA, we believe that the EMA approval with lead to further advancement of our ITV-1 as a successful therapy.”

CSO of Enzolytics, Harry Zhabilov

Despite no recent company-specific updates, ENZC stock has been gaining traction in the past few days. This could be due to the overall bullish sentiment in the biotech industry right now. It’s worth noting that its volume is also much higher than its average in the market. So keeping this in mind, will ENZC make your list of penny stocks to watch?

Penny_Stocks_to_Watch_Enzolytics_Inc._(ENZC_Stock_Chart)

Which Penny Stocks Are You Watching Right Now?

Finding the best penny stocks to buy is a careful combination of an investing strategy and the proper fundamentals. If you spend the time doing all the research you can, it can be much easier to land on a penny stock that could be worth it.

[Read More] Are These Top Penny Stocks on Your September Watchlist?

An interesting method to use is finding penny stocks that are down on the trading day, and therefore, could have the potential to rebound in the near term period. Considering all of this, which penny stocks are you watching right now?

The post Do These Penny Stocks Present a Buying Opportunity At Current Prices? appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Read More

Continue Reading

Economics

Braxia and KetaMD, CEOs McIntyre and Gumpel Speak on Acquisition

Last week, the Canadian company Braxia Scientific acquired 100% of the issued and outstanding stock of KetaMD, Inc. This is an exciting acquisition, and…

Published

on

Last week, the Canadian company Braxia Scientific acquired 100% of the issued and outstanding stock of KetaMD, Inc. This is an exciting acquisition, and in today’s interview, The Dales Report’s Nicole Hodges talks with CEOs Dr. Roger McIntyre and Warren Gumpel of Braxia Scientific and KetaMD respectively.

For some background information, KetaMD is a U.S. based, privately-held, innovative telemedicine company, with a mission to address mental health challenges via access to technology-facilitated ketamine-based treatments. Braxia Scientific is Canada’s first clinic specializing in ketamine treatments for mood disorders. They recorded revenue of $1.49m for 2022 fiscal year, ended March 31. On a year-over-year basis, revenue increased 47.5%.

Here’s some highlights from the interview.

KetaMD gives Braxia a presence in the US

Dr. McIntyre says that KetaMD gives Braxia what they’ve had as their vision from the beginning: a US presence. KetaMD is a living program. It’s already running, has infrastructure, and patients. McIntyre believes that a program like KetaMD is something Braxia’s needed to scale and obtain commercial success.

With telemedicine, Braxia has a potential to serve a gap in access. The zeitgeist of “patient going to medicine” has flipped, McIntyre says. “Now it’s medicine goes to the patient, and that is long overdue.”

COVID speeding a trend that was already happening

In 2020, 80% of physicians indicated they had virtual visits. That’s a number up from 22% the year before. But this is something that many doctors, McIntyre included, believe always should have happened. The pandemic only was the catalyst for innovation and making the option viable.

While some treatments will always need a clinic or a hospital, McIntyre believes some treatments can be done safely at home. And they are, for many chronic diseases. He feels implementing ketamine and psychedelics would be among these treatments where service could be expanded into the home. It would require careful SOPs in place, best practices, and surveillance. But he believes Braxia Scientific could deliver this with KetaMD.

Gumpel to stay as CEO of KetaMD

Gumpel says that KetaMD benefits in this acquisition from being part of the world’s most prominent researchers in depression, psychedelics, and ketamine. In the acquisition, he’ll stay on as CEO. He admits that Dr. McIntyre has been a huge part of collecting the data on the safety of ketamine treatment, and has a strong motivation to “see this thing through until most of society can access that – or at least the people that need it and want it.”

Gumpel admits he has a personal connection to ketamine treatment. As a person who has experienced bouts of depression for years, it saved his life, he says. He is grateful he was living within walking distance of ketamine treatment in Manhattan. It made him extremely aware of the accessibility gap, which in part inspired KetaMD.

Be sure to tune in for the full interview regarding Braxia and KetaMD, right here on The Dales Report!

The post Braxia and KetaMD, CEOs McIntyre and Gumpel Speak on Acquisition appeared first on The Dales Report.

Read More

Continue Reading

Spread & Containment

How to Use Dividends to Find the Best Tech Stock

Investors Alley
How to Use Dividends to Find the Best Tech Stock
When we talk about tech stock investing, we hear discussions of all sorts about different…

Published

on

Investors Alley
How to Use Dividends to Find the Best Tech Stock

When we talk about tech stock investing, we hear discussions of all sorts about different measures used for picking stocks.

For example, some tech investors use year-over-year revenue growth. Others subscribe to a theory that has been floating around for many years, that the secret to picking tech stocks was looking at the percentage of cash flows spent on research and development.

All too often, tech stock analysis consists of storytelling and searching for ideas that will change the world, something I’ve heard thousands of times during my career. The number of companies that actually did change the world probably totals up to a few dozen over three decades.

Some of those beat the market. Others did not.

I have found a variable that can help tech investors spot promising opportunities to identify technology companies that have higher probabilities of providing market-beating returns: dividends.

Note a stock’s dividend yield: investors who want higher dividends with an overall total return would be smart to look into high-yield tech stocks as part of their income strategy. The key to using dividends to find market-beating tech stocks is to look at the rate of their dividend growth. It doesn’t matter how high the dividend is at any given time. We want to see companies that are consistently growing their dividends.

A tech company that pays a dividend is making a statement. It tells the world: “We are generating enough cash to pay the bills, hire great people, and fund our future growth plans as well as R&D. In fact, we are generating so much cash we have some left over to pay out to our investors.”

Ideally, we want to limit our universe of companies to those who are increasing their payout by at least 20% annually. Growing a dividend at that high a rate says that things are just continuing to get better.

Once we have a universe of tech companies that are growing their payouts at high levels, we want to make sure we only own those that really do have a wonderful business that just keeps getting better. We want to use a financial checklist to make sure our companies are in excellent financial shape and have what it takes to keep growing the business.

I prefer the nine-point checklist developed by Professor Joseph Piotroski when he was at the University of Chicago – known as the “Piotroski F-Score”. This is a list of nine criteria of profitability, leverage, and efficiency. On each criterion, a firm can either get one or zero points – pass or fail.

I limit my universe of tech stocks with paid dividend growth to just two to three with the highest scores on the Piotroski checklist.

Using this simple method for picking tech stock winners has crushed the S&P 500 over the past decade and even edged at the tech-heavy NASDAQ 100.

Texas Instruments (TXN) makes the current list of technology companies with high dividend growth and outstanding fundamentals and prospects. The company makes most of its revenues from semiconductors, but it does still have some revenues from its calculators and other business machines. (I have had one of these, a Texas BAII calculator, within arm’s reach for most of my career.)

Texas Instruments had a solid second quarter and increased its guidance for the third quarter. The company has not suffered the China slowdown problems that have plagued some of their competitors so far. The brightest spot in the recent report was semiconductors being sold to the automobile industry, which were up 20%.

Although we have seen some slowdown in semiconductors due to the supply chain issues created by the pandemic, Texas Instruments has powerful tailwinds from all the developments we see in technology over the next decade.

Every one of the hottest trends in the economy—from renewable energy to artificial intelligence and everything in between—is going to increase demand for semiconductor chips. There are thousands of semiconductors in every electric vehicle, which will be another massive source of demand for the industry.

Texas Instruments has a yield of 2.5% right now, and has been growing that payout by 20.5% annually.

Another semiconductor company, Broadcom (AVGO) has the fastest-growing payout on our list right now. The company makes chips for smartphones, networking, broadband, and wireless connectivity. Broadcom’s recent purchase of Symantec’s Enterprise Business also puts it in the cybersecurity business.

Broadcom’s shares currently yield 2.97% and the payment has risen by an average of 49% annually for the past five years.

Most investors will never think of using dividends as part of the stock selection process. Rigorous testing shows that dividend growth is actually an important part of identifying companies with the potential to be huge winners.

My favorite way to invest in those companies isn’t to buy their stock, though. Instead, I like to use a special, little-known investment that lets me invest in these companies for up to 18% less than what others pay…

While collecting twice or more the dividend yield!

All without any more risk. I’m tracking 5 opportunities like that right now, and I lay them all out right here.

Only 3% of investors even know these funds exist

But using them, I can beat the market 2-to-1 while collecting 2-10X MORE yield from regular dividend stocks.

I learned this trick while I was rubbing elbows with some of the biggest fund managers in US history.

They too are buying these little known funds, cashing in huge discounts and collecting income while they do it.

Click here to learn the secret yourself.

 

How to Use Dividends to Find the Best Tech Stock
Tim Melvin

Read More

Continue Reading

Government

Where Carnival, Norwegian, Royal Caribbean Sit on Covid Vaccines

Do You still need to be vaccinated to go on a Royal Caribbean, Carnival, or Norwegian Cruise?

Published

on

Do You still need to be vaccinated to go on a Royal Caribbean, Carnival, or Norwegian Cruise?

Cruise line covid-19 vaccination and testing rules, which were imposed by the Centers for Disease Control and Prevention at the beginning of the pandemic, have been stricter than most. After the pandemic started in early 2020, the CDC signed a No Sail Order on March 14, 2020, which was finally lifted after nearly eight months on Oct. 30, 2020.

After the No Sail Order was lifted, the CDC enacted extremely restrictive rules and regulations to help keep passengers safe with the covid pandemic still raging throughout the world. The rules and regulations were set forth to begin to return cruise lines to operational status.

The cruise lines first had to be staffed accordingly and set up with the ability to test, treat and quarantine for covid medical emergencies. Testing for crew and passengers before embarkment and before dis-embarkment was required. The testing at pre-embarkment was a measure to protect those boarding, while the post-trip testing was for determining if an infection started on the cruise line itself. Being able to track the virus was very important in the prevention of spreading the virus and protecting patrons.

Image source: Shutterstock

Vaccination Still Not a Free Pass to Board

Once the vaccination was developed and approved, it became part of the CDC guidelines for cruise line adult passengers to have their vaccination before boarding. Even with a vaccination, guests still needed to test before they boarded the cruise lines. As the vaccine was approved for younger age groups, those age groups were then also required to have the vaccine to travel. Passengers were required to be fully vaccinated unless they are exempt by some status.

Before boarding, cruise line passengers who tested positive, as well as their travel companions, were not allowed to board, depending on the cruise line and how long the cruise may be. Some passengers were allowed to board and then isolate, others would have to reschedule their trip. Trip insurance is a good buy these days.

Cruise Lines Letting Loose on Vaccine Policies

Carnival Cruise Line  (CCL) - Get Carnival Corporation Report has now removed pre-cruise testing for vaccinated guests and also welcomes unvaccinated guests to travel. Fully vaccinated guests traveling less than 16 nights with the cruise line will no longer be subjected to testing, but still must provide proof of their vaccination status. Unvaccinated travelers will only need to provide a negative covid test result to board the ships. All rules and regulations are still subject to the destination country’s guidelines.

According to the Healthy Sail Center for Royal Caribbean  (RCL) - Get Royal Caribbean Group Report, the cruise line has updated its covid vaccination protocol. The cruise line will now allow passengers regardless of vaccination status to board in some ports if the travelers meet the testing requirements. Testing requirements vary by cruise departure and destination. Check the cruise lines port departure for updated information on requirements.

There is, however, a major exception, at least for now, which is obvious when you look at the specific wording shared by the cruise line:

"Starting with September 5 departures, all travelers regardless of vaccination status can cruise on the following itineraries, as long as they meet any testing requirements to board.

  • Cruises from Los Angeles, California.
  • Cruises from Galveston, Texas.
  • Cruises from New Orleans, Louisiana.
  • Cruises from a European homeport.

Notice that Florida, a major port for the cruise line, is not currently on the list.

In the U.S. aside from Florida, any guest with a valid negative covid test within the last three days will be able to board. These guests will also not be required to take a second test at the boarding terminal. Fully vaccinated guests do not need to provide proof of a negative covid test for shorter cruises. See the cruise line website for all updated information as it is subject to change.

Beginning Sept. 3, Norwegian Cruise Line  (NCLH) - Get Norwegian Cruise Line Holdings Ltd. Report is dropping its covid vaccine requirements for all its cruises. The cruise line stated that it is continuing to follow requirements for all destination countries, so guests traveling will want to check on destination vaccine and testing requirements. All guests 12 and older regardless of vaccination need to show proof of a negative test within 72 hours. Check NCL online for further instructions prior to travel.

The CDC has taken the stance that travelers are now well informed enough to make their own decisions when it comes to traveling on cruise lines. The travelers are taking their own assumed risk for their health and well-being. Cruise lines are now welcoming this new freedom for their passengers. 

Read More

Continue Reading

Trending